These are diseases for which stem cell treatments have not been proven to have any efficacy in human beings. In a "Phase I" clinical trial, the purpose of the study is to find out if the therapy makes any difference in the course of the disease, as compared to a control group. Some doctors may also be giving stem cells to patients in experiments outside of clinical trials, but in the United States such experiments are subject to limitations imposed by FDA regulations.

 

Auto-Immune Diseases Ø   Arthritis, Juvenile Ø   Arthritis, Rheumatoid Ø   Crohn's Disease Ø   Diabetes, Type I Ø   Evan Syndrome Ø   Juvenile Dermatomyositis Ø   Scleroderma Ø   Lupus	Nerve cell repair Diseases of the Central Nervous System Amyotrophic Lateral Sclerosis  (ALS, or "Lou Gehrig's disease") Ø   Alzheimer's Disease Ø   Huntington's Disease Ø   Parkinson's Disease   Traumatic injury Ø   Spinal cord injury Ø   Stroke recovery
Gene Therapy  (ie: Transplanting genetically altered stem cells) Ø   Fanconi's Anemia Ø   Metabolic Disorders (Leukodystrophy Diseases, Storage Disorders, etc.) Ø   Parkinson's Disease	Organ repair Kidney Ø   Combined transplant of kidney plus hematopoietic stem cells Ø   Growth of renal cells from hematopoietic stem cells   Liver Ø   Growth of liver cells from hematopoietic stem cells